http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83b3524021b88579647571621f0d7531
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Franceschi |
| name | Silvia Franceschi |
| given-name | Silvia |
| organization-name | International Agency for Research on Cancer, Lyon Cedex, France International Agency for Research on Cancer Lyon France 2International Agency for Research on Cancer, Lyon, France. 5IARC, Lyon, France; and Aviano National Cancer Institute Aviano Italy Cancer Epidemiology Unit, CRO Aviano National Cancer Institute IRCCS Aviano Italy 2Unit of Field and Intervention Studies, IARC, Lyon, France; and « Mario Negri » Institute for Pharmacological Research, Milan, Italy Authors' Affiliations: 1International Agency for Research on Cancer (IARC), Lyon, France; 2Gillings School of Global Public Health; 3School of Medicine; 4Otolaryngology/Head and Neck Surgery; and 5Lineberger Comprehensive Cancer Site, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 6University of Pittsburgh, Pittsburgh, Pennsylvania; 7Instituto de Investigación Epidemiológica, San José, Costa Rica; 8National Cancer Institute, IRCSS, Aviano, Italy; 9Brown University, Providence, Rhode Island; 10Boston University School of Public Health, Boston, Massachusetts; 11Department of Otorhinolaryngology and Head and Neck Surgery, Maastricht University Medical Site, Maastricht; and 12Department of Gastroenterology, Radboud University Nijmegen Medical Site, Nijmegen, the Netherlands; 13Pomeranian Medical University, Department of Genetics and Pathomorphology, International Hereditary Cancer Site, Szczecin, Poland; 14Penn State College of Medicine, Hershey, Pennsylvania; 15Un Servizio di Epidemiologia, Centro di Riferimento Oncologico, Aviano (PN) Centro di Riferimento Oncologico, Aviano, Milan Centro di Riferimento Oncologico (CRO), IRCCS Aviano Italy Agency for Research on Cancer, Lyon, France. 1Istituto di Ricerche Farmacologiche “Mario Negri,” Via Giuseppe La Masa 19; and 2Istituto di Statistica Medica e Biometria “G.A. Maccacaro”, Università degli Studi di Milano, Via Venezian 1, Milan, Italy; 3S.O.C. Unità di Epidemiologia e Biostatistica, Centro di Riferimento Oncologico, Via Gallino 2, Aviano (Pordenone), Italy; and 4Unità di Epidemiologia, Istituto Tumori “Fondazione Pascale,” Via Mariano Semmola, Naples, Italy; 5IARC, 150 Cours Albert Thomas, cedex 08, Lyon, France CRO Aviano National Cancer Institute IRCCS Aviano Italy Centro di Riferimento Oncologico di Aviano (CRO), IRCCS Aviano Italy International Agency for Research on Cancer; 150 cours Albert Thomas 69372 Lyon Cedex 08 France International Agency for Research on Cancer; Lyon; France Anil K. Chaturvedi, William F. Anderson, and Philip S. Rosenberg, National Cancer Institute, Rockville, MD; Maura L. Gillison, The Ohio State University, Columbus, OH; Joannie Lortet-Tieulent, Jacques Ferlay, Silvia Franceschi, and Freddie Bray, International Agency for Research on Cancer; and Maria Paula Curado, International Prevention Research Institute, Lyon, France. International Agency for Research on Cancer; 69372 Lyon Cedex 08 France Cancer Epidemiology Unit, Aviano National Cancer Institute IRCCS Aviano Italy Cancer Epidemiology Unit, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano, Italy Istituto di Ricerche Farmacologiche « Mario Negri », Milano Authors' Affiliations: 1Department of Genome Modifications and Carcinogenesis, Infection and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany; and 2International Agency for Research on Cancer, Lyon, France IARC, Lyon, France 2IARC, Lyon, France; Scientific Directorate, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France. Electronic address: franceschi@iarc.fr. 18Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France. Authors' Affiliations: 1Biostatistics Branch and 2Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland; 3Epidemiology Group, Department of Pathology; 4Department of Pathology, School of Medicine, University of the Republic; 5Deneo-Pellegrini, Director, Department of Pathology, Cancer Institute; 6Unit of Oncology and Radiotherapy, Pereira Rossell Women's Hospital, Montevideo; 7IUCLAEH School of Medicine, Maldonado, Uruguay; 8The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York; 9Post-Graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil; 10Nubia Muñoz, Cancer Institute of Colombia, Bogota, Colombia; 11Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France; and 12Catalan Institute of Oncology (ICO), IDIBELL, CIBERESP, L'Hospitalet de Llobregat 08908, Catalonia, Spain International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon cedex 08, France. Infections Section International Agency for Research on Cancer Lyon France 1IARC, Lyon, France; Centro di Riferimento Oncologico, Aviano (PN), Italy Authors' Affiliations: 1Istituto di Statistica Medica e Biometria “Giulio A. Maccacaro” and 2Dipartimento di Medicina, Chirurgia e Odontoiatria, Università degli Studi di Milano; 3Dipartimento di Epidemiologia, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy; 4Struttura Complessa Statistica Medica, Biometria e Bioinformatica, Fondazione IRCSS Istituto Nazionale Tumori di Milano, Milan, Italy; 5Clinica Otorinolaringoiatrica, DNTB, Università degli Studi di Milano, Milan, Italy; 6Cattedra di Igiene ed Epidemiologia, DPMSC, Università degli Studi di Udine, Udine, Italy; 7International Agency for Research on Cancer, Lyon, France; and 8Struttura Operativa Complessa Epidemiologia e Biostatistica, Centro di Riferimento Oncologico, Aviano, Italy 3International Agency for Research on Cancer, Lyon, France; 1International Agency for Research on Cancer (IARC), Lyon, France and Authors' Affiliations: 1International Agency for Research on Cancer, Lyon, France; 2Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat (Barcelona), Catalonia, Spain; 3Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark; 4Danish Cancer Society, Institute of Cancer Epidemiology, Diet, Cancer and Health, Copenhagen, Denmark; 5Inserm, Centre for Research in Epidemiology and Population, Health, U1018, Institut Gustave Roussy, Villejuif, France; 6Paris South University, UMRS 1018, F-94805, Villejuif, France; 7Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 8German Institute of Human Nutrition, Potsdam-Rehbrücke, Nuthetal, Germany; 9WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece; 10Hellenic Health Foundation, Athens, Greece; 11Department of Epidemiology, H From the Istituto Superiore di Sanità, Rome; La Sapienza University, Rome; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo e Sofferenza Hospital, San Giovanni Rotondo; University of Palermo; Federico II University, Naples; Riuniti Hospital, Reggio Calabria; University of Bari; Montefiascone Hospital; Riuniti Hospital, Bergamo; University of Sassari; Catholic University, Rome, Italy; and International Agency for Research on Cancer, Lyon, France 6IARC, Lyon, France; Unit of Field and Intervention Studies, International Agency for Research on Cancer, Lyon, France e Centro di Riferimento Oncologico , Aviano, Pordenone, 33081, Italy 8IARC, Lyon, France Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN) (Italy). Joint last authors. Authors' Affiliations: 1Department of Public Health, Ministry of Health, Port Vila, Efate, Vanuatu; 2International Agency for Research on Cancer, Lyon, France; 3The University of Queensland Diamantina Institute, The University of Queensland; 4Department of Pathology, VU University Medical Center (VU-UMC), Amsterdam, The Netherlands; and 5Australians Helping Abroad, Brisbane, Queensland, Australia Infections and Cancer Epidemiology, International Agency for Research in Cancer, Lyon, France; International Agency for Research on Cancer 150 Cours Albert Thomas, Lyon Cedex 08 France 1International Agency for Research on Cancer; Infections and Cancer Epidemiology Group International Agency for Research on Cancer (IARC) Lyon France 1International Agency for Research on Cancer, Lyon, France; 8International Agency for Research on Cancer, Lyon, France Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. Centro di Riferimento Oncologico IRCCS, Aviano, Italy. International Agency for Research on Cancer World Health Organization Lyon France 3IARC, Lyon, France; and International Agency for Research on Cancer, 69372 Lyon Cedex 08, France. Electronic address: franceschi@iarc.fr. International Agency for Research on Cancer, 150 cours Albert Thomas, 69008 Lyon, France. franceschi@iarc.fr International Agency for Research on Cancer 69372 Lyon cedex 08 France 6IARC, Lyon, France Authors' Affiliations: 1Cancer Epidemiology Unit; 2Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford; 3The School of Public Health; 4Department of Epidemiology and Biotatistics, School of Public Health, Imperial College London, London; 5Department of Public Health and Primary Care; 6MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom; 7Department of Surgery, Lund University Hospital, Lund; 8Malmö Diet and Cancer Study, Lund University, Malmö; 9Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm; Departments of 10Medical Biosciences, Pathology; 11Surgical and Perioperative Science; and 12Radiation Sciences, Oncology, Umeå University, Umeå, Sweden; 13International Agency for Research on Cancer, Lyon; 14Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team; 15Université Paris Sud, UMRS 1018; 16Institut G Direzione Scientifica, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy Authors' Affiliations: 1International Agency for Research on Cancer, Lyon France; 2Aviano Cancer Center, Aviano, Italy; 3Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France; 4Imperial College London, London, United Kingdom; 5Centre of Chronic Immunodeficiency, Freiburg Medical Centre and University of Freiburg, Freiburg, Germany; 6Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom; 7Julius Center for Health Sciences and Primary Care, Department of Epidemiology, University of Utrecht, Utrecht, the Netherlands; 8 Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark; 9Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 10German Institute of Human Nutrition, Potsdam-Rehbrücke, Nuthetal, Germany; 11German Cancer Research Center (DKFZ), Heidelberg, Germany; 12WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical Sc Epidemiology Unit, Centro di Riferimento Oncologico, Aviano 10IARC, Lyon, France;; 11Servizio di Epidemiologia e Biostatistica, Centro di Riferimento Oncologico, Aviano, Italy; International Agency for Research on Cancer; Lyon France From City of Health and Science, Turin, Italy, and International Agency for Research on Cancer, Lyon, France. Field and Intervention Study Unit, International Agency for Research on Cancer, Lyon, France. Authors' Affiliations: 1Istituto di Ricerche Farmacologiche “Mario Negri” and 2Dipartimento di Medicina del Lavoro “Clinica del Lavoro Luigi Devoto,” Sezione di Statistica Medica e Biometria “Giulio A. Maccacaro,” Università degli Studi di Milano, Milan, Italy; 3National Cancer Institute, Bethesda, Maryland; 4Institut Universitaire de Médecine Sociale et Préventive, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; 5New York Eye and Ear Infirmary, 6Division of Epidemiology, New York University School of Medicine, and 7The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York; 8Departments of Epidemiology and Environmental Health Sciences, University of Michigan School of Public Health and Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan; 9Brown University, Providence, Rhode Island; 10Aviano Cancer Centre, Aviano, Italy; 11Boston University School of Public Health, Boston, Massachusetts; 12International Agency for Research Authors' Affiliations: 1International Agency for Research on Cancer, Lyon, France; 2Vrije University Medical Center, Amsterdam, the Netherlands; and 3Proyecto Epidemiológico Guanacaste, Fundacion INCIENSA, San José, Costa Rica Authors' Affiliations: 1International Agency for Research on Cancer, Lyon, France; 2Institut National de la Santé et de la Recherche Médicale U618, Université François Rabelais, Tours, France; 3Department of Radiation Oncology, University of California-San Francisco, San Francisco, California; 4Institut Català d'Oncología, Barcelona, Spain; 5Centro de Investigacíon Biomedica en Red de Epidemiología y Salud Pública, Barcelona, Spain; 6National Cancer Institute, Hanoi, Vietnam; 7Neonatology Department, Hung Vuong Hospital, Ho Chi Minh City, Vietnam; 8Universidad de Buenos Aires, Facultad de Medicina, Instituto de Oncología “Angel H. Roffo,” Buenos Aires, Argentina; 9Research Institute, National Cancer Centre, Goyang, Korea; 10Research Division, National Cancer Institute, Bangkok, Thailand; 11College of Medicine, University of Ibadan, Ibadan, Nigeria; 12VU University Medical Center, Amsterdam, the Netherlands; 13Instituto Nacional de Cancerología, Bogota, Colombia; and 14Proyecto Epidemiológico Guanacaste, Fund Aimée R. Kreimer, Krystle A. Lang Kuhs, and Allan Hildesheim, National Cancer Institute, National Institutes of Health, Bethesda, MD; Pagona Lagiou and Dimitrios Trichopoulos, Harvard School of Public Health, Boston, MA; Paul Brennan, Gary Clifford, Silvia Franceschi, and Mattias Johansson, International Agency for Research on Cancer, Lyon; Françoise Clavel-Chapelon, Marie-Christine Boutron-Ruault, and Sylvie Mesrine, Institut National de la Santé et de la Recherche Médicale, Centre for Research in... IARC Lyon, France From Istituto di Ricerche Farmacologiche Mario Negri; 20157 Milan, Italy; International Agency for Research on Cancer; 69372 Lyon Cedex, France; and Istituto di Statistica Medica e Biometria, Universit degli Studi di Milano; 20133 Milan, Italy.Grant Support: By the Italian Association for Cancer Research, Milan, Italy. International Agency for Research on Cancer (IARC) Lyon France Servizio di Epidemiologia, Centro di Riferimento Oncologico, Aviano (Pordenone) Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano, IRCCS, Aviano, Italy. International Agency for Research on Cancer F‐69372 Lyon France From the Istituto di Ricerche Farmacologiche “Mario Negri” (M.S., L.C., E.N., F.P., C. La V.), Milan; Prima Clinica Ostetrico-ginecologica, Università di Milano (F.P.), Milan; Servizio di Epidemiologia, Centro di Riferimento Oncologico (S.F.), Aviano; and Istituto di Statistica Medica e Biometria, Università degli Studi di Milano (C. La V.), Milan, Italy. International Agency for Research on Cancer, Lyon, France International Agency for Research on Cancer, Lyon, France; International Agency for Research on Cancer; 69372 Lyon cedex 08 France Epidemiology Unit, Aviano, Italy. Cancer Epidemiology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy Cancer Epidemiology Unit CRO Aviano National Cancer Institute IRCCS Aviano Italy Servizio di Epidemiologia, Centro di Riferimento Oncologico, Aviano, Pordenone 6International Agency for Research on Cancer, Lyon, France; International Agency for Research on Cancer,Lyon,France 6IARC, Lyon Cedex, France 7IARC, Lyon, France Epidemiology Unit, Aviano Cancer Center, Aviano International Agency for Research on Cancer, Lyon, France. Infections and Cancer Epidemiology, International Agency for Research on Cancer (IARC), Lyon, France Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy 4International Agency for Research on Cancer, Lyon, France 2International Agency for Research on Cancer, Lyon, France International Agency for Research on Cancer 150 cours Albert Thomas, 69372 Lyon cedex 08 France Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy 6International Agency for Research on Cancer, Lyon, France Servizio di Epidemiologia, Centro di Riferimento Oncologico, Aviano (PN), Italy IRCCS CRO National Cancer Institute Aviano Italy 7Aviano Cancer Centre, Via Franco Gallini 2, 33081 Aviano (PN), Italy International Agency for Research on Cancer (IARC); Lyon France Epidemiology Unit, Aviano Cancer Center, Aviano (Pordenone), Denver, Colorado, U.S.A.; European Organization for Cooperation for Cancer Prevention Studies - Hormones, Sexual Factors & Cancer Group, Denver, Colorado, U.S.A. |
Incoming Links
Total number of triples: 912.